Abstract
Background: Hepatocellular carcinoma (HCC) is the sixth leading cause of
cancer-related mortality worldwide and the most frequent type of primary liver
cancer. HCC is diagnosed in the laboratory using either fine-needle
cytology, which is invasive and has intra- or inter-observer variability or
measuring circulating biomarkers. In combination
with ultrasonography and computed tomography, several prognostic and diagnostic
indicators are helpful
in the clinical practice of screening and diagnosing HCC. Aim of work: To give an overview of serum biomarkers of
HCC.
Comments